Changes in elf score during treatment with pegylated interferon and silymarin are associated with progression of histological liver disease in non-responder patients with chronic hepatitis c

Authors
Category Primary study
JournalGut
Year 2011
This article has no abstract
Epistemonikos ID: b676a59222c8bf1ae9beb581adf7a17a04bb2074
First added on: Feb 04, 2025